Opticyte
Opticyte, with a valuation of $12.08 million, is raising funds on StartEngine. The company has developed a breakthrough device for accurate oxygen measurements. Opticyte’s VitalO2 device measures oxygen accurately for all skin tones and enables early detection of sepsis to close critical healthcare gaps. The AI-enabled device combines advanced pulse oximetry and cellular oxygenation for early detection of sepsis and early signs of organ failure and enables quicker intervention and better patient outcomes. Lorilee Siu Lin Arakaki and Kenneth Schenkman founded Opticyte in May 2016. The current crowdfunding campaign has a minimum and maximum target of $123,999.81. The campaign proceeds will be used for design, pivotal study for early recognition of sepsis, completion of algorithm development, and working capital.
Investment Overview
Raised: $158,671
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 11/01/2024
- Close Date
- 02/13/2025
$124,000
$1,235,000
$301
Equity - Common
Seed
RegCF
$0.33
$12,078,000
Company & Team
Company
- Year Founded
- 2016
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $3,000,000
- VC Backed?
- Yes
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 02/13/2025 | StartEngine | $12,078,000 | $158,671 | Equity - Common | Active | RegCF |